Our Firm
Schlichter, Bogard & Denton is an experienced, national leader in Digitek, Enbrel, Ethex and gadolinium litigation. We have successfully taken on the largest drug companies on behalf of our clients—winning major jury verdicts and settlements that make pharmaceutical products safer.
Unlike many firms, we prepare every pharmaceutical case for an actual trial. We know how to achieve the highest and best results for our clients.
Our attorneys aggressively pursue pharmaceutical companies that put profits before patients. Our highest priority is obtaining the maximum possible recovery for each of our clients.
Schlichter, Bogard & Denton’s Contingent Fee Basis
The drug injury lawyers at Schlichter, Bogard & Denton work exclusively on a contingent fee basis. We only receive a fee if we collect money for our client. Potential clients who speak to us receive free legal advice. We answer any and all questions a potential client might have and then decide whether it is worthwhile for a client to proceed with a case.
If we take the case, no fees are due unless there is a settlement or recovery at trial. This means we share the risks of recovery with our clients in every case. Many pharmaceutical litigation firms expect compensation, regardless of the outcome of a case. We are confident of the cases we handle and we share in the risk of no recovery.
The Pharmaceutical Attorneys at Schlichter, Bogard & Denton: Protecting the Rights of the Injured
We are committed to protecting the rights of persons injured by pharmaceutical companies. If you are suffering from the effects of a dangerous drug like Digitek, Enbrel, Ethex or gadolinium, our attorneys can help you. Contact us for a free consultation at our toll free number 1-800-873-5297 or use the Free Case Evaluation Form.
